GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
196 hedge funds and large institutions have $2.35B invested in Global Blood Therapeutics, Inc. in 2018 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 86 increasing their positions, 48 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
11% more funds holding
Funds holding: 176 → 196 (+20)
3% less capital invested
Capital invested by funds: $2.41B → $2.35B (-$61.8M)
Holders
196
Holding in Top 10
7
Calls
$180M
Puts
$87.2M
Top Buyers
| 1 | +$53.6M | |
| 2 | +$45.2M | |
| 3 | +$40.6M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$20.5M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$19.7M |
Top Sellers
| 1 | -$48.1M | |
| 2 | -$46.1M | |
| 3 | -$34.7M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$24.4M |
| 5 |
RI
RTW Investments
New York
|
-$22.1M |